• Home  
  • About Us  
  • Contact Us  
  • Useful Links  


  • Our Portfolio


    Investment Process


    Investment Criteria

    Wellington House
    31-34 Waterloo Street
    Birmingham B2 5TJ

    Tel: 0121 236 8855
    Fax: 0121 233 3942
    Email: mail@merciafund.co.uk

     
    Mermaid Diagnostics

    First Invested:
    Amount Invested:
    Sector:
    Web:

    July 2000
    £235,000
    Nano technology
    http://mermaid-diagnostics.co.uk

    Mermaid Diagnostics are developing quick and easy-to-use colorimetric assays which can be carried out without the need for sophisticated equipment. The tests are incorporated into a patented device called SafeTube, which keeps the reagents discrete prior to use and secure after the introduction of the test material. The first application of the technology is SmokeScreen, a urine test for smoking, specifically measuring all the breakdown products of nicotine including cotinine. This can be used to correctly identify smokers, for a semi-quantitative measure of nicotine intake or with a dedicated instrument to quantify smoking habit. A more sensitive version can detect nicotine metabolites in saliva and passive smoking levels in urine. Other tests are under development, for example providing a means to assess treatment compliance for tuberculosis, detecting the presence of Isoniazid in urine.

    Mermaid Diagnostics has been sold to Personal Screening plc.
     

    back to Our Portfolio